[ALNY] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -15.69%
YoY- -25.94%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 163,562 71,681 21,033 37,924 17,454 7,551 24,019 37.63%
PBT -243,599 -276,583 -211,080 -142,227 -112,934 -90,721 -43,480 33.23%
Tax -59 -398 361 -7,949 -5,217 -6,685 -22,091 -62.71%
NP -243,540 -276,185 -211,441 -142,227 -112,934 -90,721 -21,389 49.93%
Tax Rate - - - - - - - -
Total Cost 407,102 347,866 232,474 180,151 130,388 98,272 45,408 44.08%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -148.90 -385.30 -1,005.28 -375.03 -647.04 -1,201.44 -89.05 8.93%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.09 -2.47 -2.09 -1.48 -1.32 -1.07 -0.28 39.75%
EPS Diluted -2.09 -2.47 -2.09 -1.48 -1.32 -1.07 -0.28 39.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.